Overview

Safety and Effects of Ramipril Combined With Candesartan

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
we hypothesized that combination therapy has additive beneficial effects to improve endothelial dysfunction and adipocytokine profiles in patients with hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Gachon University Gil Medical Center
Treatments:
Candesartan
Candesartan cilexetil
Ramipril